Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Deep Medicine Acquisition Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 S-4 Form S-4 - Registration of securities, business combinations:
07/24/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/24/2023 8-K Quarterly results
07/18/2023 8-K Quarterly results
07/14/2023 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss...
07/12/2023 8-K Quarterly results
06/16/2023 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
06/06/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/03/2023 SC 13G/A Weiss Asset Management LP reports a 0% stake in DEEP MEDICINE ACQUISITION CORP.
01/31/2023 SC 13G/A Yakira Capital Management, Inc. reports a 0% stake in Deep Medicine Acquisition Corp.
01/26/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
01/10/2023 SC 13G/A Karpus Management, Inc. reports a
12/12/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/02/2022 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
11/22/2022 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events  Interactive Data
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/24/2022 8-K Quarterly results
10/20/2022 8-K Quarterly results
09/30/2022 8-K Quarterly results
09/20/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/20/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Due Diligence Period”), DMAC and its Representatives shall undertake a due diligence review of the Company Entities and their operations; and complete DMAC’ s own determination of the Valuation . DMAC shall notify the Company of the Revised Valuation at or prior to the end of the Due Diligence Period."
09/12/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Due Diligence Period”), DMAC and its Representatives shall undertake a due diligence review of the Company Entities and their operations; and complete DMAC’ s own determination of the Valuation . DMAC shall notify the Company of the Revised Valuation at or prior to the end of the Due Diligence Period."
09/12/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/03/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/18/2022 425 Form 425 - Prospectuses and communications, business combinations:
07/18/2022 8-K Quarterly results
07/13/2022 425 Form 425 - Prospectuses and communications, business combinations:
07/13/2022 8-K Quarterly results
06/24/2022 10-K Annual Report for the period ended March 31, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy